Story perspectives

Nafisa Ali’s Cancer Progression Leads to Targeted Therapy

By Drooid · Sep 14, 2026, 4:30 PM UTC · How we work

Summary

Nafisa Ali Battles Cancer

Nafisa Ali, 69, announced her ovarian/peritoneal cancer has progressed and she is now on targeted therapy.
A PET/CT scan revealed new cancer deposits on the surface of her liver.
She posted a smiling Instagram photo from a hospital bed holding an IV drip bag on Sunday.
She thanked followers, writing “fighting the good fight.”
She appeared in the 2022 film Uunchai and the 2026 release Max, Min & Meowzaki.

Summary

Gupta Details Targeted Therapy

Dr. Puneet Gupta, Chairman of Oncology Services at Asian Hospital, says targeted therapy attacks specific molecular pathways, unlike chemotherapy.
Eligibility for targeted therapy often requires biomarker or genetic testing to confirm a treatable molecular target.
PET/CT scans combine metabolic and anatomical imaging to locate active cancer sites and assess spread.
Doctors consider scan results, prior imaging, symptoms, and overall health before altering a patient’s treatment plan.

1 of 2

Nafisa Ali Battles Cancer

Nafisa Ali, 69, announced her ovarian/peritoneal cancer has progressed and she is now on targeted therapy.
A PET/CT scan revealed new cancer deposits on the surface of her liver.
She posted a smiling Instagram photo from a hospital bed holding an IV drip bag on Sunday.
She thanked followers, writing “fighting the good fight.”
She appeared in the 2022 film Uunchai and the 2026 release Max, Min & Meowzaki.

1 / 2